<p><b>A</b>: Groups of 5 Balb/C mice were challenged with PBS, 6.2, 12.5 or 25 mg/kg of <i>E. coli</i> LPS by intraperitoneal (ip) injection. <b>B</b>: Mice (5 per group) were challenged with 500 µl of PBS, Gal 3 (40 µM), 6.2 mg/kg LPS or with a mixture of LPS (6.2 mg/kg) and Gal 3 (40 µM) preincubated for 15 min. The mortality rate was monitored regularly and represented as percentage of survival. *p<0.05.</p
<p>Adult female B6 mice were inoculated with LPS (i.p.) at doses ranging from 5 mg/kg to 40 mg/kg at...
<p>(A-B) Pathological changes of lung tissues as determined by H&E staining (200×, n = 5). (C) Body ...
<p>Mice were administered intragastrically with Ber (50 mg/kg) or/and Y (2 mg/kg) once a day for 3 d...
<p>Survival curve of mice treated with LPS (8 mg/kg, i.p.) on day 0. Mice were pre-treated with vehi...
<p>Kinetics of mortality of groups of mice (n = 6) intraperitoneally inoculated with LPS from <i>S</...
<p>After lethal dose of LPS challenge (11 mg/kg, i.p.), mice were monitored for 7 days to determine ...
<p>Mice were treated with PBS or LPS (10 µg/mouse) for 3 h (Panels A–C) and 24 h (Panels D–E) and th...
<p>Mice were administered intraperitoneally once with 200 µl PBS that contained 0, 15, 25, or 50 µg ...
<p>Data are shown as mean ± SEM for 6 mice per treatment group. Clear bars represent PBS-treated mic...
Although LPS tolerance is well-characterized, it remains unknown if it is achieved even with single ...
<p>LPS treatment (100 mg/kg, ip) significantly decreased the survival rate in B6 mice (Panel A and B...
<p>Mice were infected by intra-peritoneal injection of 0.5 ml of PBS containing 10<sup>8</sup> CFUs ...
<p>WT and gpx-1<sup>−/−</sup> mice were treated with LPS (10 µg/mouse) for 3 h and 20S proteasome co...
<p>(<b>A</b>) Comparison of proteinuria between PBS-treated (PBS) and Gal-9-treated (Gal-9) MRL/lpr ...
<p>A. BALB/c mice were divided in two groups (n = 10 for each group), one group was only i.p. inject...
<p>Adult female B6 mice were inoculated with LPS (i.p.) at doses ranging from 5 mg/kg to 40 mg/kg at...
<p>(A-B) Pathological changes of lung tissues as determined by H&E staining (200×, n = 5). (C) Body ...
<p>Mice were administered intragastrically with Ber (50 mg/kg) or/and Y (2 mg/kg) once a day for 3 d...
<p>Survival curve of mice treated with LPS (8 mg/kg, i.p.) on day 0. Mice were pre-treated with vehi...
<p>Kinetics of mortality of groups of mice (n = 6) intraperitoneally inoculated with LPS from <i>S</...
<p>After lethal dose of LPS challenge (11 mg/kg, i.p.), mice were monitored for 7 days to determine ...
<p>Mice were treated with PBS or LPS (10 µg/mouse) for 3 h (Panels A–C) and 24 h (Panels D–E) and th...
<p>Mice were administered intraperitoneally once with 200 µl PBS that contained 0, 15, 25, or 50 µg ...
<p>Data are shown as mean ± SEM for 6 mice per treatment group. Clear bars represent PBS-treated mic...
Although LPS tolerance is well-characterized, it remains unknown if it is achieved even with single ...
<p>LPS treatment (100 mg/kg, ip) significantly decreased the survival rate in B6 mice (Panel A and B...
<p>Mice were infected by intra-peritoneal injection of 0.5 ml of PBS containing 10<sup>8</sup> CFUs ...
<p>WT and gpx-1<sup>−/−</sup> mice were treated with LPS (10 µg/mouse) for 3 h and 20S proteasome co...
<p>(<b>A</b>) Comparison of proteinuria between PBS-treated (PBS) and Gal-9-treated (Gal-9) MRL/lpr ...
<p>A. BALB/c mice were divided in two groups (n = 10 for each group), one group was only i.p. inject...
<p>Adult female B6 mice were inoculated with LPS (i.p.) at doses ranging from 5 mg/kg to 40 mg/kg at...
<p>(A-B) Pathological changes of lung tissues as determined by H&E staining (200×, n = 5). (C) Body ...
<p>Mice were administered intragastrically with Ber (50 mg/kg) or/and Y (2 mg/kg) once a day for 3 d...